(PKG) Packaging of America - Overview
Exchange: NYSE •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US6951561090
Stock: Paper, Containers, Boxes, Packaging
Total Rating 43
Risk 81
Buy Signal -0.99
| Risk 5d forecast | |
|---|---|
| Volatility | 25.0% |
| Relative Tail Risk | -11.5% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.52 |
| Alpha | -1.57 |
| Character TTM | |
|---|---|
| Beta | 0.668 |
| Beta Downside | 0.623 |
| Drawdowns 3y | |
|---|---|
| Max DD | 28.43% |
| CAGR/Max DD | 0.82 |
EPS (Earnings per Share)
Revenue
Description: PKG Packaging of America March 04, 2026
Packaging Corporation of America (PKG) manufactures containerboard and uncoated freesheet (UFS) paper products. The company operates in two segments: Packaging and Paper.
The Packaging segment produces linerboard and corrugated packaging. These products include shipping containers, retail display boxes, and protective packaging for various goods, including food and industrial products. This segment sells directly to customers. The packaging sector is a mature industry with demand tied to consumer spending and e-commerce growth.
The Paper segment manufactures commodity and specialty papers, including office and printing papers. This segment also uses a direct sales model. The paper industry has seen declining demand for some traditional products due to digitalization.
PKG was founded in 1867 and is based in Lake Forest, Illinois. Investors can find detailed financial analysis and forecasts for PKG on ValueRay.
Headlines to watch out for
- Containerboard demand impacts packaging segment revenue
- Paper segment sales fluctuate with printing and writing needs
- Raw material costs, especially wood fiber, influence profitability
- Freight and energy expenses affect operational margins
- E-commerce growth drives corrugated packaging demand
Piotroski VR‑10 (Strict, 0-10) 6.5
| Net Income: 773.3m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.07 > 0.02 and ΔFCF/TA 0.78 > 1.0 |
| NWC/Revenue: 24.46% < 20% (prev 26.62%; Δ -2.16% < -1%) |
| CFO/TA 0.14 > 3% & CFO 1.56b > Net Income 773.3m |
| Net Debt (3.84b) to EBITDA (1.76b): 2.18 < 3 |
| Current Ratio: 3.17 > 1.5 & < 3 |
| Outstanding Shares: last quarter (89.6m) vs 12m ago 0.11% < -2% |
| Gross Margin: 21.02% > 18% (prev 0.21%; Δ 2.08k% > 0.5%) |
| Asset Turnover: 90.99% > 50% (prev 94.91%; Δ -3.91% > 0%) |
| Interest Coverage Ratio: 13.99 > 6 (EBITDA TTM 1.76b / Interest Expense TTM 79.1m) |
Altman Z'' 3.89
| A: 0.20 (Total Current Assets 3.21b - Total Current Liabilities 1.02b) / Total Assets 10.92b |
| B: 0.36 (Retained Earnings 3.93b / Total Assets 10.92b) |
| C: 0.11 (EBIT TTM 1.11b / Avg Total Assets 9.88b) |
| D: 0.61 (Book Value of Equity 3.89b / Total Liabilities 6.33b) |
| Altman-Z'' Score: 3.89 = AA |
Beneish M -2.72
| DSRI: 1.04 (Receivables 1.28b/1.15b, Revenue 8.99b/8.38b) |
| GMI: 1.01 (GM 21.02% / 21.27%) |
| AQI: 1.48 (AQ_t 0.22 / AQ_t-1 0.15) |
| SGI: 1.07 (Revenue 8.99b / 8.38b) |
| TATA: -0.07 (NI 773.3m - CFO 1.56b) / TA 10.92b) |
| Beneish M-Score: -2.72 (Cap -4..+1) = A |
What is the price of PKG shares?
As of March 15, 2026, the stock is trading at USD 222.58 with a total of 916,778 shares traded.
Over the past week, the price has changed by -3.04%, over one month by -12.40%, over three months by +5.52% and over the past year by +15.20%.
Over the past week, the price has changed by -3.04%, over one month by -12.40%, over three months by +5.52% and over the past year by +15.20%.
Is PKG a buy, sell or hold?
Packaging of America has received a consensus analysts rating of 3.82.
Therefore, it is recommended to buy PKG.
- StrongBuy: 5
- Buy: 0
- Hold: 5
- Sell: 1
- StrongSell: 0
What are the forecasts/targets for the PKG price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 231.9 | 4.2% |
| Analysts Target Price | 231.9 | 4.2% |
PKG Fundamental Data Overview March 14, 2026
P/E Trailing = 25.965
P/E Forward = 20.4918
P/S = 2.2273
P/B = 4.4
P/EG = 1.7975
Revenue TTM = 8.99b USD
EBIT TTM = 1.11b USD
EBITDA TTM = 1.76b USD
Long Term Debt = 3.97b USD (from longTermDebt, two quarters ago)
Short Term Debt = 102.1m USD (from shortTermDebt, last quarter)
Debt = 4.36b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 3.84b USD (from netDebt column, last quarter)
Enterprise Value = 23.72b USD (20.02b + Debt 4.36b - CCE 667.8m)
Interest Coverage Ratio = 13.99 (Ebit TTM 1.11b / Interest Expense TTM 79.1m)
EV/FCF = 32.55x (Enterprise Value 23.72b / FCF TTM 728.6m)
FCF Yield = 3.07% (FCF TTM 728.6m / Enterprise Value 23.72b)
FCF Margin = 8.11% (FCF TTM 728.6m / Revenue TTM 8.99b)
Net Margin = 8.60% (Net Income TTM 773.3m / Revenue TTM 8.99b)
Gross Margin = 21.02% ((Revenue TTM 8.99b - Cost of Revenue TTM 7.10b) / Revenue TTM)
Gross Margin QoQ = 18.93% (prev 21.80%)
Tobins Q-Ratio = 2.17 (Enterprise Value 23.72b / Total Assets 10.92b)
Interest Expense / Debt = 0.77% (Interest Expense 33.8m / Debt 4.36b)
Taxrate = 24.37% (32.8m / 134.6m)
NOPAT = 837.2m (EBIT 1.11b * (1 - 24.37%))
Current Ratio = 3.17 (Total Current Assets 3.21b / Total Current Liabilities 1.02b)
Debt / Equity = 0.95 (Debt 4.36b / totalStockholderEquity, last quarter 4.60b)
Debt / EBITDA = 2.18 (Net Debt 3.84b / EBITDA 1.76b)
Debt / FCF = 5.26 (Net Debt 3.84b / FCF TTM 728.6m)
Total Stockholder Equity = 4.62b (last 4 quarters mean from totalStockholderEquity)
RoA = 7.83% (Net Income 773.3m / Total Assets 10.92b)
RoE = 16.73% (Net Income TTM 773.3m / Total Stockholder Equity 4.62b)
RoCE = 12.89% (EBIT 1.11b / Capital Employed (Equity 4.62b + L.T.Debt 3.97b))
RoIC = 11.01% (NOPAT 837.2m / Invested Capital 7.60b)
WACC = 6.98% (E(20.02b)/V(24.39b) * Re(8.38%) + D(4.36b)/V(24.39b) * Rd(0.77%) * (1-Tc(0.24)))
Discount Rate = 8.38% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -33.33 | Cagr: -0.01%
[DCF] Terminal Value 84.25% ; FCFF base≈645.1m ; Y1≈769.6m ; Y5≈1.21b
[DCF] Fair Price = 245.0 (EV 25.88b - Net Debt 3.84b = Equity 22.05b / Shares 90.0m; r=6.98% [WACC]; 5y FCF grow 20.59% → 2.90% )
EPS Correlation: -18.35 | EPS CAGR: -4.15% | SUE: -1.08 | # QB: 0
Revenue Correlation: 46.84 | Revenue CAGR: 2.73% | SUE: -2.87 | # QB: 0
EPS next Quarter (2026-06-30): EPS=2.77 | Chg7d=+0.000 | Chg30d=+0.117 | Revisions Net=+0 | Analysts=7
EPS current Year (2026-12-31): EPS=10.84 | Chg7d=+0.008 | Chg30d=-0.304 | Revisions Net=-5 | Growth EPS=+10.1% | Growth Revenue=+12.3%
EPS next Year (2027-12-31): EPS=12.21 | Chg7d=-0.066 | Chg30d=-0.144 | Revisions Net=-2 | Growth EPS=+12.7% | Growth Revenue=+4.7%
[Analyst] Revisions Ratio: +0.00 (2 Up / 2 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 4.5% (Discount Rate 8.4% - Earnings Yield 3.9%)
[Growth] Growth Spread = +11.9% (Analyst 16.4% - Implied 4.5%)
P/E Forward = 20.4918
P/S = 2.2273
P/B = 4.4
P/EG = 1.7975
Revenue TTM = 8.99b USD
EBIT TTM = 1.11b USD
EBITDA TTM = 1.76b USD
Long Term Debt = 3.97b USD (from longTermDebt, two quarters ago)
Short Term Debt = 102.1m USD (from shortTermDebt, last quarter)
Debt = 4.36b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 3.84b USD (from netDebt column, last quarter)
Enterprise Value = 23.72b USD (20.02b + Debt 4.36b - CCE 667.8m)
Interest Coverage Ratio = 13.99 (Ebit TTM 1.11b / Interest Expense TTM 79.1m)
EV/FCF = 32.55x (Enterprise Value 23.72b / FCF TTM 728.6m)
FCF Yield = 3.07% (FCF TTM 728.6m / Enterprise Value 23.72b)
FCF Margin = 8.11% (FCF TTM 728.6m / Revenue TTM 8.99b)
Net Margin = 8.60% (Net Income TTM 773.3m / Revenue TTM 8.99b)
Gross Margin = 21.02% ((Revenue TTM 8.99b - Cost of Revenue TTM 7.10b) / Revenue TTM)
Gross Margin QoQ = 18.93% (prev 21.80%)
Tobins Q-Ratio = 2.17 (Enterprise Value 23.72b / Total Assets 10.92b)
Interest Expense / Debt = 0.77% (Interest Expense 33.8m / Debt 4.36b)
Taxrate = 24.37% (32.8m / 134.6m)
NOPAT = 837.2m (EBIT 1.11b * (1 - 24.37%))
Current Ratio = 3.17 (Total Current Assets 3.21b / Total Current Liabilities 1.02b)
Debt / Equity = 0.95 (Debt 4.36b / totalStockholderEquity, last quarter 4.60b)
Debt / EBITDA = 2.18 (Net Debt 3.84b / EBITDA 1.76b)
Debt / FCF = 5.26 (Net Debt 3.84b / FCF TTM 728.6m)
Total Stockholder Equity = 4.62b (last 4 quarters mean from totalStockholderEquity)
RoA = 7.83% (Net Income 773.3m / Total Assets 10.92b)
RoE = 16.73% (Net Income TTM 773.3m / Total Stockholder Equity 4.62b)
RoCE = 12.89% (EBIT 1.11b / Capital Employed (Equity 4.62b + L.T.Debt 3.97b))
RoIC = 11.01% (NOPAT 837.2m / Invested Capital 7.60b)
WACC = 6.98% (E(20.02b)/V(24.39b) * Re(8.38%) + D(4.36b)/V(24.39b) * Rd(0.77%) * (1-Tc(0.24)))
Discount Rate = 8.38% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -33.33 | Cagr: -0.01%
[DCF] Terminal Value 84.25% ; FCFF base≈645.1m ; Y1≈769.6m ; Y5≈1.21b
[DCF] Fair Price = 245.0 (EV 25.88b - Net Debt 3.84b = Equity 22.05b / Shares 90.0m; r=6.98% [WACC]; 5y FCF grow 20.59% → 2.90% )
EPS Correlation: -18.35 | EPS CAGR: -4.15% | SUE: -1.08 | # QB: 0
Revenue Correlation: 46.84 | Revenue CAGR: 2.73% | SUE: -2.87 | # QB: 0
EPS next Quarter (2026-06-30): EPS=2.77 | Chg7d=+0.000 | Chg30d=+0.117 | Revisions Net=+0 | Analysts=7
EPS current Year (2026-12-31): EPS=10.84 | Chg7d=+0.008 | Chg30d=-0.304 | Revisions Net=-5 | Growth EPS=+10.1% | Growth Revenue=+12.3%
EPS next Year (2027-12-31): EPS=12.21 | Chg7d=-0.066 | Chg30d=-0.144 | Revisions Net=-2 | Growth EPS=+12.7% | Growth Revenue=+4.7%
[Analyst] Revisions Ratio: +0.00 (2 Up / 2 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 4.5% (Discount Rate 8.4% - Earnings Yield 3.9%)
[Growth] Growth Spread = +11.9% (Analyst 16.4% - Implied 4.5%)